within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01D_OtherBetaLactamAntibacterials.J01DC03_Cefamandole;

model Cefamandole
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C(
    weight = 70,
    F = 1,
    Cl = 1.9799999999999997e-06,
    adminDuration = 600,
    adminMass = 1000 / 1000000,
    adminCount = 1,
    Vd = 0.0106,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Cefamandole</td></tr><tr><td>ATC code:</td><td>J01DC03</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>1000</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>10.6</td><td>L</td></tr>
    <tr><td>clearance:</td><td>118.8</td><td>ml/min</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Cefamandole is a second-generation cephalosporin antibiotic, formerly used for the treatment of bacterial infections such as respiratory tract infections, urinary tract infections, and skin and soft tissue infections. It has activity against a broad spectrum of Gram-positive and Gram-negative bacteria. Due to concerns regarding safety, including hypoprothrombinemia and disulfiram-like reactions, and availability of safer alternatives, cefamandole is rarely used or approved today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics determined in healthy adult volunteers after single intravenous injection.</p><h4>References</h4><ol><li><p>Heikkilä, HJ (1999). New models for pharmacokinetic data based on a generalized Weibull distribution. <i>Journal of biopharmaceutical statistics</i> 9(1) 89–107. DOI:<a href=\"https://doi.org/10.1081/BIP-100101002\">10.1081/BIP-100101002</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/10091912/\">https://pubmed.ncbi.nlm.nih.gov/10091912</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.J.J01DC03 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Cefamandole;
